Juvenile Dermatomyositis. Case Report

Czech version

Authors: K. Honzíková; H. Bučková
Authors‘ workplace: Dětské kožní oddělení PEK FN Brno a LF MU v Brně, primář MUDr. Hana Bučková, Ph. D.
Published in: Čes-slov Derm, 94, 2019, No. 3, p. 108-112
Category: Case Reports

Overview

Juvenile dermatomyositis is the most common idiopathic inflammatory myopathy in children. It primarily affects the skin and the muscles. This article describes a case of 14-year-old boy with predominantly skin symptoms. The authors present up-to-date diagnostic criteria and treatment possibilities.

Keywords:

therapy – juvenile dermatomyositis

Sources

1. ROWN, V. E., PILKINGTON, C. A., FELDMAN, B. M., DAVIDSON, J. E. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis. Rheumatology, 2006, 45(8), p. 990–993.

2. COOPER, M. A. WILLINGHAM, D. L., BROWN, D. E. et al. Rituximab for the treatment of juvenile dermatomyositis: A report of four pediatric patient. Arthritis & Rheumatism, 2007, 56(9), p. 3107–3111.

3. ENDERS, F. B, BADER-MEUNIER, B., BAILDAM, E. et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis published online first: August 11, 2016 doi: 10.1136/annrheumdis-2016-209247.

4. MENDEZ, E. P., LIPTON, R., RAMSAY-GOLDMAN, R., ROETTCHER, P. et al. US incidence of juvenile dermatomyositis, 1995–1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis care & research, 2003, 49(3), p. 300–305.

5. PACHMAN, L. M., LIPTON, R., RAMSEY-GOLDMAN, R., SHAMIYEH, E. et. al. History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis care & research, 2005, 53(2), p. 166–172.

6. PALLER, A. S., MANCINI, A. J. Hurwitz Clinical Pediatric Dermatology. 4^th edition, 2011, p. 509–514.

7. PETTY, R. E., LAXER, R. M., LINDSLEY, C. B., WEDDERBURN L. Textbook of Pediatric Rheumatology, 7^th edition, 2016, p. 350–382.

8. RUPERTO, N., PISTORIO, A., OLIVEIRA, S. et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial for the Paediatric Rheumatology International Trials Organisation (PRINTO), 2016, 387(10019), p. 671–678.

9. STRINGER, E., SINGH-GREWAL, D., FELDMAN, B. M. Predicting the course of juvenile dermatomyositis: Significance of early clinical and laboratory features. Arthritis & rheumatology, 2008, 58(11), p. 3585–359.

10. ŠTORK, J. et al. Dermatovenerologie. 2. vydání, Praha, Galén, 2013, p. 225-227, ISBN 978-80-7262-898-8.